ResApp Health Sign Software Licensing Agreement with Phenix Health
On 16 June 2020, ResApp and Phenix Health signed a licensing deal for employing ResAppDx-EU in telehealth smartphone application of Phenix. This agreement is a non-exclusive commercial software licensing agreement for two years. With this deal, ResAppDx-EU can be applied in the telehealth smartphone applications by Phenix Health in Australia starting 1 July.
For the full article please visit: https://kalkinemedia.com/au/healthcare/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1